Frontiers in Neuroscience,
Journal Year:
2020,
Volume and Issue:
14
Published: Aug. 6, 2020
The
blood-brain
barrier
(BBB)
is
a
dynamic
but
solid
shield
in
the
cerebral
microvascular
system.
It
plays
pivotal
role
maintaining
central
nervous
system
(CNS)
homeostasis
by
regulating
exchange
of
materials
between
circulation
and
brain,
protects
neural
tissue
from
neurotoxic
components
as
well
pathogens.
Here,
we
discuss
development
BBB
physiological
conditions
then
focus
on
cerebrovascular
disease,
including
acute
ischemic
stroke
intracerebral
hemorrhage,
neurodegenerative
disorders,
such
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
multiple
sclerosis
(MS).
Finally,
summarize
recent
advancements
therapies
targeting
outline
future
directions
outstanding
questions
field.
We
propose
that
dysfunction
not
only
results
causal
pathogenesis
neurological
disorders;
more
contributor
to
disruption
CNS
than
victim
disorders.
Molecular Psychiatry,
Journal Year:
2022,
Volume and Issue:
27(6), P. 2659 - 2673
Published: March 31, 2022
Abstract
The
blood-brain
barrier
(BBB)
is
vital
for
maintaining
brain
homeostasis
by
enabling
an
exquisite
control
of
exchange
compounds
between
the
blood
and
parenchyma.
Moreover,
BBB
prevents
unwanted
toxins
pathogens
from
entering
brain.
This
barrier,
however,
breaks
down
with
age
further
disruption
a
hallmark
many
age-related
disorders.
Several
drugs
have
been
explored,
thus
far,
to
protect
or
restore
function.
With
recent
connection
gut
microbiota,
microbial-derived
metabolites
explored
their
capabilities
physiology.
review,
will
focus
on
components
that
make
up
BBB,
dissect
levels
discuss
current
therapeutics
maintain
integrity
discoveries
effects
Frontiers in Physiology,
Journal Year:
2020,
Volume and Issue:
11
Published: Aug. 6, 2020
The
blood-brain
barrier
(BBB)
allows
the
brain
to
selectively
import
nutrients
and
energy
critical
neuronal
function
while
simultaneously
excluding
neurotoxic
substances
from
peripheral
circulation.
In
contrast
highly
permeable
vasculature
present
in
most
organs
that
reside
outside
of
central
nervous
system
(CNS),
BBB
exhibits
a
high
transendothelial
electrical
resistance
along
with
low
rate
transcytosis
greatly
restricted
paracellular
permeability.
property
permeability
is
controlled
by
tight
junction
protein
complexes
seal
route
between
apposing
microvascular
endothelial
cells.
Although
are
principal
contributors
physical
properties,
they
not
static
nature.
Rather,
dynamic
structures
where
expression
and/or
localization
individual
constituent
proteins
can
be
modified
response
pathophysiological
stressors.
These
stressors
induce
modifications
involve
de
novo
synthesis
new
or
discrete
trafficking
mechanisms.
Such
responsiveness
junctions
diseases
indicates
these
for
maintenance
CNS
homeostasis.
fulfillment
this
vital
role,
also
major
obstacle
therapeutic
drug
delivery
brain.
There
an
opportunity
overcome
substantial
optimize
neuropharmacology
via
acquisition
detailed
understanding
structure,
function,
regulation.
review,
we
discuss
physiological
characteristics
how
properties
regulate
therapeutics
treatment
neurological
diseases.
Specifically,
will
modulation
regulation
both
context
disease
states
setting
pharmacotherapy.
particular,
highlight
potentially
manipulated
at
molecular
level
increase
levels
transport
Journal of Cerebral Blood Flow & Metabolism,
Journal Year:
2020,
Volume and Issue:
40(1_suppl), P. S6 - S24
Published: Sept. 14, 2020
The
blood–brain
barrier
(BBB)
is
a
critical
regulator
of
CNS
homeostasis.
It
possesses
physical
and
biochemical
characteristics
(i.e.
tight
junction
protein
complexes,
transporters)
that
are
necessary
for
the
BBB
to
perform
this
physiological
role.
Microvascular
endothelial
cells
require
support
from
astrocytes,
pericytes,
microglia,
neurons,
constituents
extracellular
matrix.
This
intricate
relationship
implies
existence
neurovascular
unit
(NVU).
NVU
cellular
components
can
be
activated
in
disease
contribute
dynamic
remodeling
BBB.
especially
true
resident
immune
brain,
which
polarize
into
distinct
proinflammatory
(M1)
or
anti-inflammatory
(M2)
phenotypes.
Current
data
indicate
M1
pro-inflammatory
microglia
dysfunction
vascular
“leak”,
while
M2
play
protective
role
at
Understanding
biological
mechanisms
involved
activation
provides
unique
opportunity
develop
novel
treatment
approaches
neurological
diseases.
In
review,
we
highlight
describe
how
these
phenotypes
modulate
physiology.
Additionally,
outline
other
cell
types
regulating
microglial
targeted
with
focus
on
ischemic
stroke
Alzheimer’s
disease.
Frontiers in Neurology,
Journal Year:
2020,
Volume and Issue:
11
Published: Dec. 9, 2020
The
blood-brain
barrier
(BBB)
is
a
dynamic
interface
responsible
for
maintaining
the
central
nervous
system
homeostasis.
Its
unique
characteristics
allow
protecting
brain
from
unwanted
compounds,
but
its
impairment
involved
in
vast
number
of
pathological
conditions.
Disruption
BBB
and
increase
permeability
are
key
development
several
neurological
diseases
have
been
extensively
studied
stroke.
Ischemic
stroke
most
prevalent
type
characterized
by
myriad
events
triggered
an
arterial
occlusion
that
can
eventually
lead
to
fatal
outcomes
such
as
hemorrhagic
transformation
(HT).
seems
follow
multiphasic
pattern
throughout
different
stages
associated
with
distinct
biological
substrates.
In
hyperacute
stage,
sudden
hypoxia
damages
BBB,
leading
cytotoxic
edema
increased
permeability;
acute
neuroinflammatory
response
aggravates
injury,
higher
consequent
risk
HT
be
motivated
reperfusion
therapy;
subacute
stage
(1-3
weeks),
repair
mechanisms
take
place,
especially
neoangiogenesis.
Immature
vessels
show
leaky
this
has
improved
clinical
recovery.
chronic
(>6
restoration
factors
leads
start
decreasing
permeability.
Nonetheless,
will
persist
some
degree
weeks
after
injury.
Understanding
behind
dysregulation
pathophysiology
could
potentially
help
guide
care
decisions
new
therapeutic
targets;
however,
effective
translation
into
practice
still
lacking.
review,
we
address
physiological
through
ischemic
their
role
Journal of Neuroinflammation,
Journal Year:
2020,
Volume and Issue:
17(1)
Published: Aug. 1, 2020
Obstructive
sleep
apnea
syndrome
(OSAS),
a
state
of
disorder,
is
characterized
by
repetitive
apnea,
chronic
hypoxia,
oxygen
desaturation,
and
hypercapnia.
Previous
studies
have
revealed
that
intermittent
hypoxia
(IH)
conditions
in
OSAS
patients
elicited
neuron
injury
(especially
the
hippocampus
cortex),
leading
to
cognitive
dysfunction,
significant
extraordinary
complication
patients.
The
repeated
courses
airway
collapse
obstruction
resulted
arousal
during
sleep,
IH
excessive
daytime
sleepiness
(EDS)
subsequently
contributing
development
inflammation.
IH-mediated
inflammation
could
further
trigger
various
types
dysfunction.
Many
researchers
found
that,
besides
continuous
positive
pressure
(CPAP)
treatment
surgery,
anti-inflammatory
substances
might
alleviate
IH-induced
neurocognitive
Clarifying
role
impairment
crucial
for
potentially
valuable
therapies
future
research
related
domain.
objective
this
article
was
critically
review
relationship
between
deficits
OSAS.
Advanced Materials,
Journal Year:
2019,
Volume and Issue:
31(21)
Published: April 8, 2019
Reperfusion
injury
exists
as
the
major
obstacle
to
full
recovery
of
neuron
functions
after
ischemic
stroke
onset
and
clinical
thrombolytic
therapies.
Complex
cellular
cascades
including
oxidative
stress,
neuroinflammation,
brain
vascular
impairment
occur
within
neurovascular
units,
leading
microthrombus
formation
ultimate
death.
In
this
work,
a
multitarget
micelle
system
is
developed
simultaneously
modulate
various
cell
types
involved
in
these
events.
Briefly,
rapamycin
encapsulated
self-assembled
micelles
that
are
consisted
reactive
oxygen
species
(ROS)-responsive
fibrin-binding
polymers
achieve
retention
controlled
drug
release
lesion.
Neuron
survival
reinforced
by
combination
facilitated
ROS
elimination
antistress
signaling
pathway
interference
under
ischemia
conditions.
vivo
results
demonstrate
an
overall
remodeling
unit
through
polarized
M2
microglia
repair
blood-brain
barrier
preservation,
enhanced
neuroprotection
blood
perfusion.
This
strategy
gives
proof
concept
units
can
serve
integrated
target
for
treatment
with
nanomedicines.
Brain Research,
Journal Year:
2022,
Volume and Issue:
1788, P. 147937 - 147937
Published: May 11, 2022
The
blood-brain
barrier
(BBB)
is
a
dynamic
structure
that
protects
the
brain
from
harmful
blood-borne,
endogenous
and
exogenous
substances
maintains
homeostatic
microenvironment.
All
constituent
cell
types
play
indispensable
roles
in
BBB's
integrity,
other
structural
BBB
components,
such
as
tight
junction
proteins,
adherens
junctions,
junctional
can
control
permeability.
Regarding
need
to
exchange
nutrients
toxic
materials,
solute
carriers,
ATP-binding
case
families,
ion
transporter,
well
transcytosis
regulate
influx
efflux
transport,
while
difference
localisation
expression
contribute
functional
differences
transport
properties.
Numerous
chemical
mediators
factors
non-physicochemical
have
been
identified
alter
permeability
by
mediating
components
function,
because
of
close
relationship
with
inflammation.
In
this
review,
we
highlight
recently
gained
mechanistic
insights
into
maintenance
disruption
BBB.
A
better
understanding
influencing
could
supporting
promising
potential
therapeutic
targets
for
protecting
delivery
central
nervous
system
drugs
via
interventions
under
pathological
conditions.
Cells,
Journal Year:
2021,
Volume and Issue:
10(10), P. 2712 - 2712
Published: Oct. 10, 2021
Forming
the
inner
layer
of
vascular
system,
endothelial
cells
(ECs)
facilitate
a
multitude
crucial
physiological
processes
throughout
body.
Vascular
ECs
enable
vessel
wall
passage
nutrients
and
diffusion
oxygen
from
blood
into
adjacent
cellular
structures.
regulate
tone
coagulation
as
well
adhesion
transmigration
circulating
cells.
The
EC
functions
is
reflected
by
tremendous
diversity.
can
form
extremely
tight
barriers,
thereby
restricting
xenobiotics
or
immune
cell
invasion,
whereas,
in
other
organ
systems,
fenestrated
(e.g.,
glomeruli
kidney),
discontinuous
liver
sinusoids)
less
dense
to
allow
for
rapid
molecular
exchange.
not
only
differ
between
organs
they
also
change
along
tree
specialized
subpopulations
be
found
within
capillaries
single
organ.
Molecular
tools
that
selective
targeting
are
helpful
experimentally
dissect
role
distinct
populations,
improve
imaging
pave
way
novel
treatment
options
diseases.
This
review
provides
an
overview
diversity
highlights
most
successful
methods
subpopulations.
Cells,
Journal Year:
2021,
Volume and Issue:
10(6), P. 1548 - 1548
Published: June 19, 2021
Diseases
of
the
central
nervous
system
(CNS)
remain
a
significant
health,
social
and
economic
problem
around
globe.
The
development
therapeutic
strategies
for
CNS
conditions
has
suffered
due
to
poor
understanding
underlying
pathologies
that
manifest
them.
Understanding
common
etiological
origins
at
cellular
molecular
level
is
essential
enhance
efficacious
targeted
treatment
options.
Over
years,
neuroinflammation
been
posited
as
link
between
multiple
neurological,
neurodegenerative
neuropsychiatric
disorders.
Processes
precipitate
neuroinflammatory
including
genetics,
infections,
physical
injury
psychosocial
factors,
like
stress
trauma,
closely
dysregulation
in
kynurenine
pathway
(KP)
tryptophan
metabolism
possible
pathophysiological
factor
'fuel
fire'
diseases.
In
this
study,
we
aim
review
emerging
evidence
provide
mechanistic
insights
different
disorders,
KP.
We
thorough
overview
branches
KP
pertinent
disease
pathology
have
implications
selected
strategies.